PURIFICATION OF THE 5-HYDROXYTRYPTAMINE 5-HT3 RECEPTOR FROM NCB20 CELLS

被引:0
|
作者
MCKERNAN, RM [1 ]
GILLARD, NP [1 ]
QUIRK, K [1 ]
KNEEN, CO [1 ]
STEVENSON, GI [1 ]
SWAIN, CJ [1 ]
RAGAN, CI [1 ]
机构
[1] MERCK SHARP & DOHME LTD,NEUROSCI RES CTR,DEPT CHEM,HARLOW CM20 2QR,ESSEX,ENGLAND
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A 5-hydroxytryptamine 5-HT3 receptor binding site has been purified from deoxycholate-solubilized NCB20 cell membranes. Purification (1,700-fold) was achieved in one step by affinity chromatography with L-685,603 immobilized on agarose. The 5-HT3 selective antagonist [3H]Q ICS 205-930 labeled a single population of receptors in the affinity-purified preparation with a Bmax of 3.1 ± 0.9 nmol/mg protein and Kd of 0.40 ± 0.05 nM (mean ± S.E., n = 3). The rank order of potency for a series of competing compounds confirmed that [3H]Q ICS 205,930 was labeling a 5-HT3 receptor in the purified preparation, and the inhibition constants for all antagonists were unchanged after purification. The purified 5-HT3 binding site eluted from a Sepharose 6B gel filtration column in a similar manner to the crude solubilized preparation (Stokes radius of 4.9 nm, apparent molecular size 250,000). Polyacrylamide gel electrophoresis of the affinity-purified receptor showed two broad bands by silver staining, migrating with apparent molecular masses of 54,000 and 38,000. Gel filtration of the affinity purified material yielded a single peak labeled by [3H]Q ICS 205-930 with an apparent molecular size of 250,000, which was also composed of two bands of 54,000 and 38,000, consistent with these being the constituents of the 5-HT3 receptor.
引用
收藏
页码:13572 / 13577
页数:6
相关论文
共 50 条
  • [1] MOLECULAR-SIZE OF THE 5-HT3 RECEPTOR SOLUBILIZED FROM NCB 20 CELLS
    MCKERNAN, RM
    BIGGS, CS
    GILLARD, N
    QUIRK, K
    RAGAN, CI
    BIOCHEMICAL JOURNAL, 1990, 269 (03) : 623 - 628
  • [2] 5-HT3 AGONISTS CAN DISTINGUISH CLONED 5-HT3 RECEPTORS FROM NCB20 AND NG108-15 CELL-LINES
    SEPULVEDA, MI
    LUMMIS, SCR
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 : U160 - U160
  • [3] Mechanism of block by fluoxetine of 5-hydroxytryptamine3 (5-HT3)-mediated currents in NCB-20 neuroblastoma cells
    Choi, JS
    Choi, BH
    Ahn, HS
    Kim, MJ
    Rhie, DJ
    Yoon, SH
    Min, DS
    Jo, YH
    Kim, MS
    Sung, KW
    Hahn, SJ
    BIOCHEMICAL PHARMACOLOGY, 2003, 66 (11) : 2125 - 2132
  • [4] Direct effects of riluzole on 5-hydroxytryptamine (5-HT)3 receptor-activated ion currents in NCB-20 neuroblastoma cells
    Kim, Ki Jung
    Cho, Hyeong Seok
    Choi, Se Joon
    Jeun, Seung Hyun
    Kim, Seong Yun
    Sung, Ki-Wug
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 107 (01) : 57 - 65
  • [5] Involvement of 5-hydroxytryptamine (5-HT3) receptors in insulin resistance
    Umrani, D
    Goyal, R
    JOURNAL OF HYPERTENSION, 2000, 18 : S138 - S138
  • [6] Tricyclic antidepressant amitriptyline inhibits 5-hydroxytryptamine 3 receptor currents in NCB-20 cells
    Park, Yong Soo
    Myeong, Seok Ho
    Kim, In-Beom
    Sung, Ki-Wug
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2018, 22 (05): : 585 - 595
  • [7] 5-HYDROXYTRYPTAMINE (5-HT3) RECEPTOR ANTAGONISTS .2. 1-INDOLINECARBOXAMIDES
    BERMUDEZ, J
    DABBS, S
    JOINER, KA
    KING, FD
    JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (07) : 1929 - 1932
  • [8] EMESIS AND DEFECATIONS INDUCED BY THE 5-HYDROXYTRYPTAMINE (5-HT3) RECEPTOR ANTAGONIST ZACOPRIDE IN THE FERRET
    KING, GL
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1990, 253 (03): : 1034 - 1041
  • [9] 5-HYDROXYTRYPTAMINE (5-HT3) RECEPTOR ANTAGONISTS .3. ORTHO-SUBSTITUTED PHENYLUREAS
    BERMUDEZ, J
    DABBS, S
    KING, FD
    JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (07) : 1932 - 1935
  • [10] Phylogenetic analyses of 5-hydroxytryptamine 3 (5-HT3) receptors in Metazoa
    Rao, Santosh T. R. B.
    Turek, Ilona
    Irving, Helen R.
    PLOS ONE, 2023, 18 (03):